Learn More
Apexbio Technology LLC CNX-774 1202759-32-7 5mg

Supplier: Apexbio Technology LLC B14085

CNX-774 (CAS 1202759-32-7) is an orally bioavailable covalent and selective inhibitor of Bruton s tyrosine kinase (BTK) It forms an irreversible bond with the cysteine 481 residue in the ATP binding site of BTK In biochemical assays CNX-774 inhibits BTK activity with an IC below 1 nM in cellular assays inhibition occurs at 1 10 nM BTK plays a critical role in B cell receptor (BCR) signaling and mast cell activation processes central to B cell maturation and function CNX-774 is utilized as a tool compound in studies of B cell signaling autoimmune disease and related immune pathway research
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.